Hirtle Callaghan & Co’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-2,500
Closed -$392K 128
2018
Q4
$392K Hold
2,500
0.03% 67
2018
Q3
$444K Hold
2,500
0.04% 64
2018
Q2
$422K Hold
2,500
0.04% 67
2018
Q1
$402K Hold
2,500
0.04% 68
2017
Q4
$387K Hold
2,500
0.04% 70
2017
Q3
$355K Buy
+2,500
New +$358K 0.04% 70
2015
Q1
Sell
-59,857
Closed -$5.67M 320
2014
Q4
$5.67M Sell
59,857
-10,965
-15% -$973K 1.31% 13
2014
Q3
$5.74M Hold
70,822
0.95% 19
2014
Q2
$5.99M Hold
70,822
0.83% 22
2014
Q1
$5.79M Hold
70,822
0.96% 18
2013
Q4
$5.34M Hold
70,822
0.72% 20
2013
Q3
$4.81M Buy
+70,822
New +$4.89M 0.78% 22

Other funds holding SYK

Hirtle Callaghan & Co's SYK Position: Q1 2019 in Review

Hirtle Callaghan & Co sold out of Stryker (SYK) in Q1 2019, closing a stake of 2,500 shares — an estimated $392K sold.

Hirtle Callaghan & Co first reported a position in SYK in Q3 2013 and held it in 12 quarters. The position peaked at $5.99M in Q2 2014. 1,313 funds tracked by Wall St. Rank hold SYK as of Q1 2019.

  • Hirtle Callaghan & Co reported no remaining Stryker position as of Q1 2019 after selling out during the quarter.
  • Hirtle Callaghan & Co sold 2,500 Stryker shares in Q1 2019, an estimated $392K.
  • Hirtle Callaghan & Co first reported a position in Stryker in Q3 2013 and held it in 12 quarters.
  • Hirtle Callaghan & Co's Stryker position peaked at $5.99M in Q2 2014.
  • 1,313 funds tracked by Wall St. Rank held Stryker as of Q1 2019.

Based on Hirtle Callaghan & Co's 13F filing for Q1 2019, filed 14 May 2019.